Tag: pharmaceutical industry corruption

Virtually every single placebo-controlled drug trial in psychiatry is flawed, systematic reviews of trials are also flawed, and guidelines are flawed. Even the drug approval process is flawed.

The increased prescribing of antipsychotics, which frequently cause a brain injury that manifests as tardive dyskinesia, has provided pharmaceutical companies with a lucrative new market opportunity.

Malcharist, by Paul John Scott, is a fictional account of one of psychiatry’s most influential key opinion leaders (KOLs), his ghostwriter, and a journalist on the trail of a big scandal in the world of Big Pharma.

Capitalists don’t discover new medicine; they invest in it. The incentive to do so, as everyone will admit, is to return a profit. Most would also agree that this profit shouldn’t be "too large," but enough to encourage adequate investment into new treatments. However, the idea that this is a well-functioning system, and indeed the best way of producing medicine, is a myth.

MIA's Gavin Crowell-Williamson interviews PharmedOut founder Dr. Adriane Fugh-Berman about Big Pharma's influence on medical education.

On The Daily Show, Michael Che interviews MIA contributor Peter Gøtzsche and discovers that pharmaceutical companies and drug cartels have more in common than one might think.